Stock listing

Roche Holding Ltd

Selected listing: RO · SIX · CHF · CH

Roche Holding Ltd (SIX Swiss: RO), Health Technology. Latest release Oct 1, 2026: Genentech Presents New Data at EURETINA, Highlighting Vabysmo’s Real-World…

RO:SIXCHFCHUpdated October 3, 2026

Ticker: SIX Swiss: RO
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: SIX Swiss
Currency: CHF

About Roche Holding Ltd

The company is known for its contributions to the healthcare sector, focusing on pharmaceuticals and diagnostics. Roche is committed to innovation and improving patient outcomes through its extensive research and development efforts.

Latest news from Roche Holding Ltd

Genentech Presents New Data at EURETINA, Highlighting Vabysmo’s Real-World Effectiveness and Safety Across Major Retinal Conditions

October 1, 2026

Roche : fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis

September 30, 2026

Roche launches newborn screening test for three severe genetic conditions

September 30, 2026

Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregon

September 28, 2026

Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)

September 23, 2026

All Roche Holding Ltd news →

Events

Replays

Roche Holding AG (RHHBY) Q2 2026 Earnings Call
Thu, Jul 23, 2026 · 08:00 AM ET
Watch
Roche Holding AG (RHHBY) Q1 2026 Earnings Call
Thu, Apr 23, 2026 · 08:00 AM ET
Watch
Roche Holding AG (RHHBY) Q4 2025 Earnings Call
Thu, Jan 29, 2026 · 07:30 AM ET
Watch

Research Roche Holding Ltd

Roche Holding Ltd company profile

View the public company page for Roche Holding Ltd on 6ix.

Roche Holding Ltd news

Read company news and market updates connected to Roche Holding Ltd.

Roche Holding Ltd investor events

Find investor webinars, events, and replay context for Roche Holding Ltd.